You are here
Improved Insulin Sensitivity by the Angiotensin II-Receptor Blocker Losartan is Not Explained by Adipokines, Inflammatory Markers, or Whole Blood Viscosity.
We have previously found improved insulin sensitivity after antihypertensive treatment with an angiotensin II-receptor blocker as compared with acalcium channel blocker in hypertensives. In this study, we compare the effect of these 2 principal different vasodilating agents on levels of...
Tags: Losartan, Amlodipine, Whole blood viscosity (WBV), Plasminogen activator inhibitor-1 (PAI-1), Tumor necrosis factor alpha (TNFα), Inflammation, C-reactive protein (CRP)